Cudetaxestat

N/A

Report date: 2026/04/12 20:00:13

NME

Base Information

Drug NameCudetaxestat

Drug Alias NamePAT-409BLD-0409

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitorsLymphocytes stimulants

TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2

Therapy Area/IndicationsIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases

ATC CodeN/A